UC San Diego Health to Provide TIL Therapy for Melanoma
|
UC San Diego Health will be the first hospital system in the region to offer a new immunotherapy treatment for metastatic melanoma. The personalized cellular therapy derived from tumor infiltrating lymphocytes (TIL) is the first solid tumor therapy on the market approved by the U.S. Food and Drug Administration.
|
|
|
New Avenues in Pancreatic Cancer Treatment: A Q&A with Corina Antal, PhD |
Pancreatic cancer is one of the most lethal cancers—due in large part to the current lack of effective treatments. Moores Member Dr. Corina Antal is leading groundbreaking research, recently funded by a V Foundation Grant, to uncover new therapeutic treatments for pancreatic cancer. In this Q&A, Dr. Antal describes the focus, importance, and impact of her research.
|
Register for the 2024 Testicular Cancer Conference
|
The Testicular Cancer Awareness Foundation will host the 2024 Testicular Cancer Conference at Moores, September 19–21, which will offer survivors, patients, and caregivers the opportunity to connect with medical experts and each other.
|
|
|
June 12, 2024 | 12:00 p.m. to 1:00 p.m.
Leichtag Biomedical Research Building, Room 107 and Zoom
|
Mentors for this session will be Sujan Shrestam PhD, Alfredo Molinolo, MD, PhD, and Lourdes Martinez, PhD. All students, postdocs, and junior faculty are welcome to attend.
|
June 13, 2024 | 12:00 p.m. to 1:00 p.m.
Zoom
|
June 14, 2024 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons and Zoom
|
Distinguished Scientist: Director’s Seminar Series
|
Thomas F. Gajewski, MD, PhD
|
July 11, 2024 | 4:00 p.m. to 5:00 p.m.
Goldberg Auditorium and Zoom
| |
|
Call for Applications: GloCal Health Fellowship 2025–2026 Cohort
|
The GloCal Health Fellowship is a 12-month, mentored research fellowship that provides aspiring global health researchers with outstanding interdisciplinary education and training in innovative research designed to improve health for populations around the world. Sponsored by the National Institutes of Health (NIH) Fogarty International Center (FIC) and the UC Global Health Institute, the GloCal Health Fellowship supports fellows from all 10 UC campuses and 22 affiliated sites across 18 countries.The fellowship is designed for not only U.S. doctoral and professional students and postdoctoral fellows, but also international postdoctoral fellows from affiliated sites in low- and middle-income countries.
For questions, please contact GloCal Health Fellowship Deputy Director, Kimberly Bale, at kimberly.bale@ucsf.edu.
|
University of California Davis, Comprehensive Course in Flow Cytometry |
ONLINE | June 24-28, 2024
|
This comprehensive, online flow cytometry course will teach you how flow cytometers work and how to design your assays to achieve reliable and reproducible results. Advanced topics (e.g., multicolor panel design, troubleshooting, data analysis, and artifact reduction) also will be covered. These topics will be complemented by best practices in analytic cytometry, cell sorting, experiment design, and analysis.
|
Fully Funded Postdoctoral Position in Pharma
|
Innomatching, the Academia-Industry Collaboration Unit of Inospin Group, is seeking proposals from outstanding final-year PhD or equivalent degree students in Computer Science, Physics, Life Sciences, or related field, who have an interest in joining a top-20 pharmaceutical company to obtain a postgraduate degree within 3 years. Proposals should feature innovative ideas on employing artificial intelligence, extended reality, and spatial computing to analyze 3D images of tissues and organs, with the aim of enhancing our understanding of morphological and molecular alterations induced by diseases and drug toxicity. Successful applicants will be awarded a fully funded postdoctoral position within the company’s R&D facility, where will have access to expertise, a fully equipped laboratory with the relevant tools (e.g., light-sheet microscope, laser scanning confocal microscope, and high power computing system), technologies, and mentoring support needed to turn their ideas into reality.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
This Notice of Funding Opportunity Announcement invites applications proposing exploratory research that targets further development and validation of emerging technologies that offer novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic, clinical, or epidemiological cancer research.
Budget/Period: $300,000/year for 3 years
Deadline: October 1, 2024
|
Damon Runyon-Rachleff Innovation Award
|
This award is designed to provide support for the next generation of creative thinkers with “high-risk/high-reward” ideas that have the potential to increase our understanding of and/or approaches to the prevention, diagnosis, and/or treatment of cancer.
Budget/Period: $800,000 over 4 years
Deadline: July 8, 2024
|
|
|
| Phase II trial of cisplatin, gemcitabine, and intensity-modulated radiation therapy for locally advanced vulvar squamous cell carcinoma: NRG Oncology/GOG Study 279
|
Journal of Clinical Oncology
|
Jyoti Mayadev, MD (Solid Tumor Therapeutics)
|
|
|
|
Post-translational modification-centric base editor screens to assess phosphorylation site functionality in high throughput
|
Patrick G. Hogan, PhD (Cancer Biology and Signaling), Alexandra C. Newton, PhD (Cancer Biology and Signaling), and Samuel A. Myers, PhD (Cancer Biology and Signaling)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
PCD19CD20-ALLO1-001: Open-Label, Multicenter, Phase 1 Study to Assess the Safety of PCD19CD20ALLO1 in Subjects with Selected Relapsed/Refractory B cell Malignancies
|
PI: Carolyn Mulroney, MD
NCT: NCT06014762
|
0486: Phase 2 Trial of the Combination of the BET Inhibitor, ZEN003694 (ZEN3694), and the PARP Inhibitor Talazoparib, in Patients With Molecularly-Selected Solid Tumors (ComBET)
|
PI: Rana McKay, MD
NCT: NCT05327010
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE) |
Somali Family Services, Women’s Health Forum
|
Over the past weekend, COE collaborated with Somali Family Services to offer the Women’s Health Forum, which targeted cervical cancer prevention and screening. Over a dozen community members participated, and COE looks forward to the next session.
|
Health Fair at the Jackie Robinson YMCA
|
TThis past Wednesday, COE tabled another health fair at the Jackie Robinson YMCA. COE connected with over 100 community members and provided cancer prevention education and resources. If you would like to join COE at future events like this one, please email COE at mcccoe@health.ucsd.edu.
|
|
|
|